Pfizer earned $3.5 billion on COVID-19 vaccine in first quarter | The Hill: Healthcare Policy

Pfizer's COVID-19 vaccine earned the company $3.5 billion in the first three months of this year, representing nearly a quarter of its total revenue, the company announced ahead of its earnings call Tuesday.The drug giant said it expects the vaccine...